Bank of America’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,800
Closed -$333K 8240
2021
Q2
$333K Buy
+24,800
New +$310K ﹤0.01% 5723
2014
Q4
Sell
-200
Closed -$3K 7795
2014
Q3
$3K Sell
200
-50,800
-100% -$1.17M ﹤0.01% 7687
2014
Q2
$1.52M Buy
+51,000
New +$1.22M ﹤0.01% 3610
2013
Q3
Sell
-70,737
Closed -$2.2M 7951
2013
Q2
$2.2M Buy
+70,737
New +$1.9M ﹤0.01% 3093

Other funds holding INVA

Bank of America's INVA Position: Q1 2026 in Review

Bank of America increased its Innoviva (INVA) stake by 6.6% in Q1 2026, buying an estimated $2.17M and bringing the position to 1,619,994 shares worth $37.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

Bank of America first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $68.3M in Q2 2014. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Bank of America held 1,619,994 shares of Innoviva worth $37.7M as of Q1 2026.
  • Bank of America bought 100,791 Innoviva shares in Q1 2026, an estimated $2.17M.
  • Innoviva made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1824 holding.
  • Bank of America first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Innoviva position peaked at $68.3M in Q2 2014.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.